Microwave ablation (MWA) is an effective minimally invasive technique for lung tumours. We aim to evaluate its role for pulmonary oligorecurrence after radical surgery of non-small-cell lung cancer (NSCLC).
From June 2012 to Jan 2020, a total of 103 patients with pulmonary oligorecurrence after previous radical surgical resection of NSCLC were retrospectively analysed. The primary endpoint was postoperative progression-free survival (PFS). Secondary endpoints were postoperative overall survival (OS), patterns of failure, complications and predictive factors associated with prognosis.
Of the 103 patients identified, 135 pulmonary oligorecurrences developed at a median interval of 34.8 months. In total, 143 sessions of MWA were performed to ablate all the nodules. The median PFS and OS were 15.1 months and 40.6 months, respectively. After MWA, 15 (14.6%) patients had local recurrence as the first event, while intrathoracic oligorecurrence and distant metastases were observed in 45 (43.7%) and 20 (19.4%) patients, respectively. In the multivariate analysis, local recurrence and intrathoracic oligorecurrence were not significant predictors for OS (P = 0.23 and 0.26, respectively). However, distant metastasis was predictive of OS (HR = 5.37, 95% CI, 1.04–27.84, P = 0.04).
MWA should be considered to be an effective and safe treatment option for selected patients with pulmonary oligorecurrence after NSCLC radical surgical resection.
Subscribe to Journal
Get full journal access for 1 year
only $4.96 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Martin, J., Ginsberg, R. J., Venkatraman, E. S., Bains, M. S., Downey, R. J., Korst, R. J. et al. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J. Clin. Oncol. 20, 1989–1995 (2002).
Takahashi, Y., Horio, H., Hato, T., Harada, M., Matsutani, N. & Kawamura, M. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected. Interact. Cardiovasc. Thorac. Surg. 21, 14–20 (2015).
Yoshino, I., Yohena, T., Kitajima, M., Ushijima, C., Nishioka, K., Ichinose, Y. et al. Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs. Ann. Thorac. Cardiovasc. Surg. 7, 204–209 (2001).
Williams, B. A., Sugimura, H., Endo, C., Nichols, F. C., Cassivi, S. D., Allen, M. S. et al. Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. Ann. Thorac. Surg. 81, 1021–1027 (2006).
Sekihara, K., Hishida, T., Yoshida, J., Oki, T., Omori, T., Katsumata, S. et al. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is ‘cured’ from postoperative recurrence? Eur. J. Cardiothorac. Surg. 52, 522–528 (2017).
Patel, P. R., Yoo, D. S., Niibe, Y., Urbanic, J. J. & Salama, J. K. A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. Pulm. Med. 2012, 480961 (2012).
Huang, F., Wu, G. & Yang, K. Oligometastasis and oligo-recurrence: more than a mirage. Radiat. Oncol. 9, 230 (2014).
Hishida, T., Yoshida, J., Aokage, K., Nagai, K. & Tsuboi, M. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†. Eur. J. Cardiothorac. Surg. 49, 847–853 (2016).
Han, S. J., Cho, S., Yum, S., Kim, K. & Jheon, S. Surgical treatment of pulmonary oligorecurrence after curative resection for non-small-cell lung cancer. Interact. Cardiovasc Thorac. Surg. 30, 18–23 (2020).
Yuan, Q., Wang, W., Zhang, Q., Wang, Y., Chi, C. & Xu, C. Clinical features and prognostic factor of thoracic postoperative oligo-recurrence of non-small-cell lung cancer. Cancer Manag Res. 12, 1397–403. (2020).
Sun, B., Brooks, E. D., Komaki, R., Liao, Z., Jeter, M., McAleer, M. et al. Long-term outcomes of salvage stereotactic ablative radiotherapy for isolated lung recurrence of non-small cell lung cancer: a phase II clinical trial. J. Thorac. Oncol. 12, 983–92. (2017).
Yang, X., Ye, X., Zheng, A., Huang, G., Ni, X., Wang, J. et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J. Surg. Oncol. 110, 758–763 (2014).
Yang, X., Ye, X., Huang, G., Han, X., Wang, J., Li, W. et al. Repeated percutaneous microwave ablation for local recurrence of inoperable Stage I nonsmall cell lung cancer. J. Cancer Res. Ther. 13, 683–688 (2017).
Vogl, T. J., Nour-Eldin, N. A., Albrecht, M. H., Kaltenbach, B., Hohenforst-Schmidt, W., Lin, H. et al. Thermal ablation of lung tumors: focus on microwave ablation. Rofo 189, 828–843 (2017).
Ni, Y., Ye, X., Yang, X., Huang, G., Li, W., Wang, J. et al. Microwave ablation for non-small cell lung cancer with synchronous solitary extracranial metastasis. J. Cancer Res. Clin. Oncol. 146, 1361–1367 (2020).
Martini, N. & Melamed, M. R. Multiple primary lung cancers. J. Thorac. Cardiovasc. Surg. 70, 606–612 (1975).
Ni, Y., Ye, X., Yang, X., Huang, G., Li, W., Wang, J. et al. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment. J. Cancer Res. Clin. Oncol. 146, 197–203 (2020).
Ye, X., Fan, W., Wang, H., Wang, J., Wang, Z., Gu, S. et al. Expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition). J. Cancer Res. Ther. 14, 730–744 (2018).
Hishida, T., Nagai, K., Yoshida, J., Nishimura, M., Ishii, G., Iwasaki, M. et al. Is surgical resection indicated for a solitary non-small cell lung cancer recurrence? J. Thorac. Cardiovasc. Surg. 131, 838–842 (2006).
Aoki, S., Yamashita, H., Takahashi, W., Nawa, K., Ota, T., Imae, T. et al. Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: a single-institution analysis of 59 patients. Oncol. Lett. 19, 2695–704. (2020).
Nishiyama, K., Kodama, K., Teshima, T. & Tada, H. Stereotactic body radiotherapy for second pulmonary nodules after operation for an initial lung cancer. Jpn. J. Clin. Oncol. 45, 947–952 (2015).
Kodama, H., Yamakado, K., Takaki, H., Kashima, M., Uraki, J., Nakatsuka, A. et al. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc. Interv. Radiol. 35, 563–569 (2012).
Okuma, T., Matsuoka, T., Yamamoto, A., Oyama, Y., Toyoshima, M., Nakamura, K. et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc. Interv. Radiol. 31, 122–130 (2008).
Wang, J., Ni, Y., Yang, X., Huang, G., Wei, Z., Li, W. et al. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity. J. Cancer Res. Ther. 15, 755–759 (2019).
Wei, Z., Yang, X., Ye, X., Huang, G., Li, W., Han, X. et al. Camrelizumab combined with microwave ablation improves the objective response rate in advanced non-small cell lung cancer. J. Cancer Res. Ther. 15, 1629–1634 (2019).
Huang, G., Ye, X., Yang, X., Wang, C., Zhang, L., Ji, G. et al. Invasive pulmonary aspergillosis secondary to microwave ablation: a multicenter retrospective study. Int. J. Hyperth. 35, 71–78 (2018).
Ethics approval and consent to participate
The ethics committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University, Renji Hospital of Jiaotong University, The First Affiliated Hospital of Shandong First Medical University, Beijing Hospital and National Geriatric Medical Center approved the study. The study was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from the subjects prior to participating in the study.
Consent to publish
All the data generated in this study are included in this paper. The data presented in this paper will be available from the corresponding author upon request.
The authors declare no competing interests.
This study has received funding from National Natural Science Foundation of China (81502610 and 82072028) and Shandong Provincial Natural Science Foundation, China (ZR201911040313).
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ni, Y., Peng, J., Yang, X. et al. Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non-small-cell lung cancer. Br J Cancer 125, 672–678 (2021). https://doi.org/10.1038/s41416-021-01404-y